LINC vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

LINC

52.6
AI Score
VS
LINC Wins

UTI

39.4
AI Score

Investment Advisor Scores

LINC

53score
Recommendation
HOLD

UTI

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric LINC UTI Winner
Forward P/E 26.6667 28.8184 LINC
PEG Ratio 1.7789 1.9191 LINC
Revenue Growth 22.4% 7.2% LINC
Earnings Growth 20.0% -78.9% LINC
Tradestie Score 52.6/100 39.4/100 LINC
Profit Margin 4.0% 3.9% LINC
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL LINC

Relative Price Performance (Last 90 Days)

LINC 1M: -16.0% · 3M: -47.4% UTI 1M: -20.8% · 3M: -50.2%

Current Technical Phase

LINC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -19.7%), weak momentum, RSI 31

RSI (14): 30.8 · Price: $25.02

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 27

RSI (14): 26.9 · Price: $20.31

Fundamentals Snapshot

Metric LINC UTI
Market Cap
Forward P/E 23.9 27.6
Trailing P/E 33.4 34.9
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.73 0.59
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LINC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.